Luke Fletcher, MD, reviews updates in anemia-predominant MDS and the 2025 polling results from MDS Case-Based Roundtable events.
Luke Fletcher, MD
Luke Fletcher, MD is the lab director and a medical oncologist/hematologist at Willamette Valley Cancer Institute.
Articles by Luke Fletcher, MD
Latest Updated Articles
Oncologists Choose Top Goals and Therapies for Treating MDSPublished: September 25th 2025 | Updated: